Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Thrombotic and Inflammatory Mediators in Cancer Patients Are Downregulated by Enoxaparin. Biochip and Protein Array Analysis

Debra Hoppensteadt, Ph.D., Evangelos Litinas, MD, Hussein Khan, Josephine Cunanan, MD, Indermohan Thethi, MD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 713.

https://doi.org/10.1182/blood.V118.21.713.713

Published: 2011

Journal Articles

Thrombin Generation Mediators and Markers in Sepsis Associated Coagulapathy,

Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Hussein Khan, Evangelos Litinas, MD, Gautam Sharma, Inder Kaul, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 3341.

https://doi.org/10.1182/blood.V118.21.3341.3341

Published: 2011

Journal Articles

Markers of Thrombogenesis Activation and Endothelial Dysfunction in End Stage Renal Disease

Vinod Bansal, MD, Korosh Sharain, Debra Hoppensteadt, Ph.D., Evangelos Litinas, MD, Bruce E Lewis, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 1151.

https://doi.org/10.1182/blood.V118.21.1151.1151

Published: 2011

Journal Articles

Identification of Unique Biomarkers in Sepsis Associated Coagulopathy

Gautam Sharma, Rahul Bijlani, Evangelos Litinas, MD, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Hussein Khan, Gautum Sharma, Inder Kaul, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 1237.

https://doi.org/10.1182/blood.V118.21.1237.1237

Published: 2011

Journal Articles

Thrombin Generation Inhibition by Newer Anti Xa and Anti IIa Drugs in Prothrombin Complex Concentrates: Relevance to Endogenous Modulation of Thrombogenesis

Angel Gray, Evangelos Litinas, MD, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Bruce E Lewis, MD, Omer Iqbal, MD, Jawed Fareed, PhD

Blood (2011) 118 (21): 1196.

https://doi.org/10.1182/blood.V118.21.1196.1196

Published: 2011

Journal Articles

Comparison of the Pharmacokinetic and Pharmacodynamic Behavior of Branded and Generic Enoxaparin in Non-Human Primates

Walter Jeske, PhD, Evangelos Litinas, MD, Hussein Khan, Debra Hoppensteadt, Ph.D., Elizabeth McGeehan, MA, CVT, Jawed Fareed, PhD

Blood (2011) 118 (21): 1254.

https://doi.org/10.1182/blood.V118.21.1254.1254

Published: 2011

Journal Articles

Cross Reactivity of Natural Hirudin Compared to the Recombinant Hirudins with Sheep Anti Hirudin Antibody

Vijaya L Paramatmuni, Debra Hoppensteadt, Ph.D., Saayi Setty, Evangelos Litinas, MD, Nasir Sadeghi, Jawed Fareed, PhD

Blood (2011) 118 (21): 4321.

https://doi.org/10.1182/blood.V118.21.4321.4321

Published: 2011

Journal Articles

Activation Markers of Thrombogenesis and Endothelial Dysfunction In End-Stage Renal Disease

Korosh Sharain, Rachael Davis, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Evangelos Litinas, MD, Vinod Bansal, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5183.

https://doi.org/10.1182/blood.V116.21.5183.5183

Published: 2010

Journal Articles

Biochip Array Profiling of Inflammatory Cytokines and Growth Factors In End-Stage Renal Disease: Hematological Implications?

Korosh Sharain, Debra Hoppensteadt, Ph.D., Josephine Cunanan, MD, Evangelos Litinas, MD, Vinod Bansal, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5184.

https://doi.org/10.1182/blood.V116.21.5184.5184

Published: 2010

Journal Articles

Upregulation of Inflammatory Mediators In End-Stage Renal Disease as Measured Via Biochip Array Technology

Vinod Bansal, MD, Rachael Davis, Evangelos Litinas, MD, Debra Hoppensteadt, Ph.D., Indermohan Thethi, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5186.

https://doi.org/10.1182/blood.V116.21.5186.5186

Published: 2010

Journal Articles

Differential Modulation of Cytokines by VEGF In End Stage Renal Disease

Vinod Bansal, MD, Debra Hoppensteadt, Ph.D., Evangelos Litinas, MD, Indermohan Thethi, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 5187.

https://doi.org/10.1182/blood.V116.21.5187.5187

Published: 2010

Journal Articles

Upregulation of Von Willebrand Factor, Von Wilelbrand Factor Propeptide, and ADMATS-13 In End-Stage Renal Disease

Jawed Fareed, PhD, Evangelos Litinas, MD, Debra Hoppensteadt, Professor, Indermohan Thethi, MD, Vinod Bansal, MD

Blood (2010) 116 (21): 5189.

https://doi.org/10.1182/blood.V116.21.5189.5189

Published: 2010

Journal Articles

Non-Pathogenic Anti-Heparin/PF4 Antibodies Generated by Low Molecular Weight Heparins Mediate Procoagulant Effects.

Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Evangelos Litinas, MD, Harry L. Messmore, Jr, MD, Bruce E Lewis, MD, Gundu Rao, PhD, Russell Hull, MD, Jawed Fareed, PhD

Blood (2010) 116 (21): 1091.

https://doi.org/10.1182/blood.V116.21.1091.1091

Published: 2010

Journal Articles

Generic Versions of Low Molecular Weight Heparin May Not Have the Same Safety-Efficacy Profile as the Branded Low Molecular Weight Heparins In Acute Coronary Syndrome.

Debra Hoppensteadt, Ph.D., Walter Jeske, Ph.D., Evangelos Litinas, MD, Omer Iqbal, MD, Jeanine M. Walenga, PhD, Bruce E Lewis, MD, Hussein Kahn, M.D., Jawed Fareed, PhD

Blood (2010) 116 (21): 1098.

https://doi.org/10.1182/blood.V116.21.1098.1098

Published: 2010

Journal Articles

Persistant Inhibition of Thrombin Generation After Intravenous Administration of Enoxaparin in Primates.

Evangelos Litinas, Angel Gray, Nasir Sadeghi, Josephine Cunanan, Debra Hoppensteadt, Jawed Fareed

Blood (2009) 114 (22): 2095.

https://doi.org/10.1182/blood.V114.22.2095.2095

Published: 2009

Journal Articles

Pharmacodynamic Differences of An Anti-Xa Enriched Low Molecular Weight Heparin, AVE 5026 in Comparison to Enoxaparin and Unfractionated Heparin.

Debra Hoppensteadt, Angel Gray, Evangelos Litinas, Brigitte Kaiser, Jawed Fareed

Blood (2009) 114 (22): 4171.

https://doi.org/10.1182/blood.V114.22.4171.4171

Published: 2009

Journal Articles

Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin

Jacqueline Kuziej, Walter Jeske, Debra Hoppensteadt, Evangelos Litinas, Elizabeth McGeehan, Jawed Fareed, PhD, Richard Kennedy

Blood (2008) 112 (11): 3018.

https://doi.org/10.1182/blood.V112.11.3018.3018

Published: 2008

Journal Articles

Increased Antithrombotic and Bleeding Effects of Contaminated Heparins; Hematological Implications

Evangelos Litinas, MD, Walter Jeske, Ph.D., Debra Hoppensteadt, Ph.D., Harry Messmore, MD, Jeanine M. Walenga, PhD, Jawed Fareed, Ph.D.

Blood (2008) 112 (11): 3021.

https://doi.org/10.1182/blood.V112.11.3021.3021

Published: 2008

Journal Articles

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

Vinod Bansal, Josephine Cunanan, Cafer Adiguzel, Evangelos Litinas, Kelly Nelson, Jawed Fareed

Blood (2008) 112 (11): 3022.

https://doi.org/10.1182/blood.V112.11.3022.3022

Published: 2008

Journal Articles

In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative.

Jacqueline Kuziej, Evangelos Litinas, Debra Hoppensteadt, Dahui Liu, Ph.D., Jeanine M. Walenga, PhD, Jawed Fareed, PhD, Walter Jeske

Blood (2008) 112 (11): 1825.

https://doi.org/10.1182/blood.V112.11.1825.1825

Published: 2008

NARROW

Thrombotic and Inflammatory Mediators in Cancer Patients Are Downregulated by Enoxaparin. Biochip and Protein Array Analysis

Thrombin Generation Mediators and Markers in Sepsis Associated Coagulapathy,

Markers of Thrombogenesis Activation and Endothelial Dysfunction in End Stage Renal Disease

Identification of Unique Biomarkers in Sepsis Associated Coagulopathy

Thrombin Generation Inhibition by Newer Anti Xa and Anti IIa Drugs in Prothrombin Complex Concentrates: Relevance to Endogenous Modulation of Thrombogenesis

Comparison of the Pharmacokinetic and Pharmacodynamic Behavior of Branded and Generic Enoxaparin in Non-Human Primates

Cross Reactivity of Natural Hirudin Compared to the Recombinant Hirudins with Sheep Anti Hirudin Antibody

Activation Markers of Thrombogenesis and Endothelial Dysfunction In End-Stage Renal Disease

Biochip Array Profiling of Inflammatory Cytokines and Growth Factors In End-Stage Renal Disease: Hematological Implications?

Upregulation of Inflammatory Mediators In End-Stage Renal Disease as Measured Via Biochip Array Technology

Differential Modulation of Cytokines by VEGF In End Stage Renal Disease

Upregulation of Von Willebrand Factor, Von Wilelbrand Factor Propeptide, and ADMATS-13 In End-Stage Renal Disease

Non-Pathogenic Anti-Heparin/PF4 Antibodies Generated by Low Molecular Weight Heparins Mediate Procoagulant Effects.

Generic Versions of Low Molecular Weight Heparin May Not Have the Same Safety-Efficacy Profile as the Branded Low Molecular Weight Heparins In Acute Coronary Syndrome.

Persistant Inhibition of Thrombin Generation After Intravenous Administration of Enoxaparin in Primates.

Pharmacodynamic Differences of An Anti-Xa Enriched Low Molecular Weight Heparin, AVE 5026 in Comparison to Enoxaparin and Unfractionated Heparin.

Pharmacoequivalence of Enoxaparin and Contaminated Enoxaparin

Increased Antithrombotic and Bleeding Effects of Contaminated Heparins; Hematological Implications

A Higher Prevalence of HIT Antibodies in Patients May Be Due to Contaminated Heparin

In Vivo Neutralization of Unfractionated Heparin and Low Molecular Weight Heparin by a Novel Salicylamide Derivative.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only